PICO Deep brain stimulation for treatment resistant depression
PICO Deep brain stimulation for treatment resistant depression. Clinical reality ?
Deep brain stimulation in the treatment of depression. Acta Psychiatr Scand, 2011 Blomstedt P et al.
Subcal. cing. gyrus (no 20) 85% had ECT HDRS - 52% / 1 year 35% remission Capsula interna (no 15) 100% had ECT HDRS -44% / 1 year 40% remission Nucleus accumbens (no 10) 100% had ECT HDRS - 36% / 1 year 30% remission
§ Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment. Resistant Depression § Biological Psychiatry, 2008 § Lozano, et al
Increased activity in the subcallosal cingulate gyrus
§ Pharmacotherapy § Transcranial magnetic stimulation § Electroconvulsive therapy Altered activity of the SCG § Deep brain stimulation Direct modulation of the SCG
Inclusion Severe Chronic Treatment resistant Failure to respond to a minimum of four different treatments § Antidepressant pharmacotherapy of sufficient dose and duration § Evidence-based psychotherapy § Electroconvulsive therapy
Exclusion § comorbid Axis I psychiatric conditions, § Axis II cluster B diagnosis § suicidal behaviour within the past year § concurrent neurological or medical conditions that could interfere with the treatment.
Subjects (n = 20) Male/female 9/11 Age at Enrollment (years) 47. 4 ± 10. 4 Age of Onset of MDD (years) 27. 1 ± 8. 3 Length of Current Episode (years) 6. 9 ± 5. 6 Number of Lifetime MDE (n) 3. 9 ± 3. 1 Received ECT (n) 17/20 Baseline HRSD-17 24. 4 ± 3. 5 3 patients received no ECT before DST All patients received medication during DST
Adverse Effect Number of Patients Wound Infection and Hardware removal 3 Reinsertion of DBS Hardware 1 Wound Infection Managed with Antibiotics Alone 1 Perioperative Seizure 1 Worsening Mood/Irritability 2 Perioperative Headache 4 Pain at Pulse Generator Site 1 No Adverse Effects 7
§ Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years § Kennedy, et al. § Am J Psychiatry, 2011
1 unrelated death 2 suicides 2 lost to follow up 3 devices removed
Argument in favour § Otherwise intractable depression § Remission rates around 30 % § Possible long term benefits
Arguments against § No clear target-area § Invasive procedure § Battery life § Open label assessment § Small N § Concurrent medication use
In conclusion § Experimental therapy § Clinical studies § Multidisciplinary teams
- Slides: 19